Torrent Pharmaceuticals Limited has informed the Exchange regarding Appointment of Ms Geena Malhotra as Other of the company w.e.f. February 01, 2026. Approved appointment of Geena Malhotra as Chief Technology Officer of the Company categorized as Senior Management Personnel with effect from 01-Feb-26
TORNTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Torrent Pharmaceuticals has approved the appointment of Ms. Geena Malhotra as the Chief Technology Officer (CTO) of the company, classified as Senior Management Personnel. Her appointment will be effective from February 01, 2026. This is a senior-level operational and technology leadership addition to the company's management team. No further details about her prior role or background were disclosed in the filing.
This is a routine senior management appointment and is unlikely to have any material impact on the stock price or shareholder value. It signals continued investment in technology leadership, which is relevant given the increasing role of digital and tech capabilities in the pharmaceutical sector.